Literature DB >> 7930782

Gastrin-releasing peptide and CCK after intraduodenal inhibition of proteases in dogs.

R Nustede1, W E Schmidt, M Jäger, F Stöckmann, H Köhler, U R Fölsch, H J Peiper.   

Abstract

The intraduodenal application of a potent protease inhibitor (camostate, 600 mg) causes a significant increase in basal pancreatic secretion in the manner of a negative-feedback mechanism. The integrated protein secretion during the entire study period was 9.9 +/- 1.8 g in 120 min. The iv application of anti-GRP immunoglobulin caused a significant reduction to 5.0 +/- g in 120 min. No significant changes in the plasma concentrations of GRP and CCK were detectable. The increased secretion occurring after the administration of the protease inhibitor could be mediated by neural GRP-dependent mechanisms. These may also be relevant for CCK-dependent factors, which are only briefly mentioned.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7930782     DOI: 10.1007/bf02924196

Source DB:  PubMed          Journal:  Int J Pancreatol        ISSN: 0169-4197


  27 in total

1.  Pancreatic secretion and the release of cholecystokinin after a meal in dogs with and without exclusion of pancreatic juice.

Authors:  M Kogire; K Inoue; R Hosotani; Y S Huang; J C Thompson; T Tobe
Journal:  Scand J Gastroenterol       Date:  1989-05       Impact factor: 2.423

2.  [Effect of gastrin releasing peptide on exocrine pancreatic secretion and plasma levels of CCK and PP in conscious dogs].

Authors:  R Hosotani; K Inoue; T Okuno; S Miyata; T Tobe
Journal:  Nihon Shokakibyo Gakkai Zasshi       Date:  1985-04

3.  Pancreatic exocrine secretion in anesthetized and conscious rats.

Authors:  H Petersen; M I Grossman
Journal:  Am J Physiol       Date:  1977-12

4.  Effects of intestinal amylase and trypsin on pancreatic secretion in the pig.

Authors:  I Ihse; P Lilja
Journal:  Scand J Gastroenterol       Date:  1979       Impact factor: 2.423

5.  Stimulation of pancreatic secretion in man by a protease inhibitor (camostate).

Authors:  G Adler; A Müllenhoff; I Koop; T Bozkurt; B Göke; C Beglinger; R Arnold
Journal:  Eur J Clin Invest       Date:  1988-02       Impact factor: 4.686

6.  Inhibition of intraduodenal trypsin does not stimulate exocrine pancreatic secretion in man.

Authors:  J Dlugosz; U R Fölsch; W Creutzfeldt
Journal:  Digestion       Date:  1983       Impact factor: 3.216

7.  Changes in plasma and duodenal cholecystokinin concentrations after pancreatic duct occlusion in rats.

Authors:  K Miyasaka; A Funakoshi; A Jimi; R Nakamura; M Matsumoto; K Kitani
Journal:  Dig Dis Sci       Date:  1992-03       Impact factor: 3.199

8.  Feedback regulation of human pancreatic secretion. Effects of protease inhibition on duodenal delivery and small intestinal transit of pancreatic enzymes.

Authors:  P Layer; J B Jansen; L Cherian; C B Lamers; H Goebell
Journal:  Gastroenterology       Date:  1990-05       Impact factor: 22.682

9.  Short-term inhibition of duodenal tryptic activity does not affect human pancreatic, biliary, or gastric function.

Authors:  J Hotz; S B Ho; V L Go; E P DiMagno
Journal:  J Lab Clin Med       Date:  1983-03

10.  Differential effects of atropine and a cholecystokinin receptor antagonist on pancreatic secretion.

Authors:  G Adler; M Reinshagen; I Koop; B Göke; A Schafmayer; L C Rovati; R Arnold
Journal:  Gastroenterology       Date:  1989-04       Impact factor: 22.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.